Chronic 0 7 0 7 B-chronic_disease
or 8 10 8 10 I-chronic_disease
acute 11 16 11 16 I-chronic_disease
GI 17 19 17 19 I-chronic_disease
disorders 20 29 20 29 I-chronic_disease
resulting 30 39 30 39 O
in 40 42 40 42 O
diarrhea 43 51 43 51 O
of 52 54 52 54 O
any 55 58 55 58 O
severity 59 67 59 67 O
grade 68 73 68 73 O

Concomitant 0 11 74 85 O
use 12 15 86 89 O
of 16 18 90 92 O
any 19 22 93 96 O
anticancer 23 33 97 107 B-treatment
therapy 34 41 108 115 I-treatment
or 42 44 116 118 O
use 45 48 119 122 O
of 49 51 123 125 O
any 52 55 126 129 O
investigational 56 71 130 145 O
agent(s 72 79 146 153 O
) 79 80 153 154 O

Enzyme 0 6 155 161 B-treatment
- 6 7 161 162 I-treatment
inducing 7 15 162 170 I-treatment
anti 16 20 171 175 I-treatment
- 20 21 175 176 I-treatment
epileptic 21 30 176 185 I-treatment
drugs 31 36 186 191 I-treatment
( 37 38 192 193 I-treatment
EIAEDs 38 44 193 199 I-treatment
) 44 45 199 200 I-treatment
within 46 52 201 207 O
14 53 55 208 210 B-upper_bound
days 56 60 211 215 I-upper_bound
of 61 63 216 218 O
randomization 64 77 219 232 O

Female 0 6 233 239 B-gender

HIV 0 3 240 243 B-chronic_disease

Last 0 4 244 248 O
dose 5 9 249 253 O
of 10 12 254 256 O
anticancer 13 23 257 267 B-treatment
therapy 24 31 268 275 I-treatment
must 32 36 276 280 O
have 37 41 281 285 O
been 42 46 286 290 O
administered 47 59 291 303 O
within 60 66 304 310 O
6 67 68 311 312 B-upper_bound
months 69 75 313 319 I-upper_bound
of 76 78 320 322 O
the 79 82 323 326 O
date 83 87 327 331 O
of 88 90 332 334 O
randomization 91 104 335 348 O
into 105 109 349 353 O
this 110 114 354 358 O
study 115 120 359 364 O

Major 0 5 365 370 B-treatment
surgery 6 13 371 378 I-treatment
within 14 20 379 385 O
28 21 23 386 388 B-upper_bound
days 24 28 389 393 I-upper_bound
prior 29 34 394 399 I-upper_bound
to 35 37 400 402 O
randomization 38 51 403 416 O

Prior 0 5 417 422 O
malignancy 6 16 423 433 B-cancer
( 17 18 434 435 O
other 18 23 435 440 O
than 24 28 441 445 O
breast 29 35 446 452 B-cancer
cancer 36 42 453 459 I-cancer
) 42 43 459 460 O
unless 44 50 461 467 O
diagnosed 51 60 468 477 O
and 61 64 478 481 O
definitively 65 77 482 494 O
treated 78 85 495 502 O
more 86 90 503 507 O
than 91 95 508 512 O
5 96 97 513 514 B-lower_bound
years 98 103 515 520 I-lower_bound
prior 104 109 521 526 I-lower_bound
to 110 112 527 529 O
randomization 113 126 530 543 B-treatment

Prior 0 5 544 549 B-treatment
treatment 6 15 550 559 I-treatment
with 16 20 560 564 O
NKTR-102 21 29 565 573 B-treatment

Significant 0 11 574 585 O
known 12 17 586 591 O
cardiovascular 18 32 592 606 B-chronic_disease
impairment 33 43 607 617 I-chronic_disease

Women 0 5 618 623 B-gender
of 6 8 624 626 O
childbearing 9 21 627 639 O
potential 22 31 640 649 O
( 32 33 650 651 O
WCBP 33 37 651 655 O
) 37 38 655 656 O
must 39 43 657 661 O
agree 44 49 662 667 B-contraception_consent
to 50 52 668 670 I-contraception_consent
use 53 56 671 674 I-contraception_consent
highly 57 63 675 681 I-contraception_consent
effective 64 73 682 691 I-contraception_consent
methods 74 81 692 699 I-contraception_consent
of 82 84 700 702 I-contraception_consent
birth 85 90 703 708 I-contraception_consent
control 91 98 709 716 I-contraception_consent
throughout 99 109 717 727 O
the 110 113 728 731 O
duration 114 122 732 740 O
of 123 125 741 743 O
the 126 129 744 747 O
study 130 135 748 753 O
until 136 141 754 759 O
6 142 143 760 761 B-upper_bound
months 144 150 762 768 I-upper_bound
following 151 160 769 778 O
the 161 164 779 782 O
last 165 169 783 787 O
dose 170 174 788 792 O
of 175 177 793 795 O
study 178 183 796 801 O
drug 184 188 802 806 O

age 0 3 807 810 B-age
â‰¥ 4 5 811 812 O
18 6 8 813 815 B-lower_bound
years 9 14 816 821 I-lower_bound

history 0 7 822 829 O
of 8 10 830 832 O
brain 11 16 833 838 B-cancer
metastases 17 27 839 849 I-cancer
that 28 32 850 854 O
are 33 36 855 858 O
non 37 40 859 862 O
- 40 41 862 863 O
progressing 41 52 863 874 O

male 0 4 875 879 B-gender

plan 0 4 880 884 B-pregnancy
to 5 7 885 887 I-pregnancy
get 8 11 888 891 I-pregnancy
pregnant 12 20 892 900 I-pregnancy

pregnant 0 8 901 909 B-pregnancy

prior 0 5 910 915 B-treatment
therapy 6 13 916 923 I-treatment
( 14 15 924 925 O
administered 15 27 925 937 O
in 28 30 938 940 O
the 31 34 941 944 O
neoadjuvant 35 46 945 956 B-treatment
, 46 47 956 957 O
adjuvant 48 56 958 966 O
, 56 57 966 967 O
and/or 58 64 968 974 O
metastatic 65 75 975 985 B-treatment
setting 76 83 986 993 I-treatment
) 83 84 993 994 O
with 85 89 995 999 O
an 90 92 1000 1002 O
anthracycline 93 106 1003 1016 B-treatment
, 106 107 1016 1017 O
a 108 109 1018 1019 O
taxane 110 116 1020 1026 B-treatment
, 116 117 1026 1027 O
and 118 121 1028 1031 O
capecitabine 122 134 1032 1044 B-treatment
( 135 136 1045 1046 O
prior 136 141 1046 1051 B-treatment
anthracycline 142 155 1052 1065 I-treatment
can 156 159 1066 1069 O
be 160 162 1070 1072 O
omitted 163 170 1073 1080 O
if 171 173 1081 1083 O
not 174 177 1084 1087 O
medically 178 187 1088 1097 O
appropriate 188 199 1098 1109 O
or 200 202 1110 1112 O
contraindicated 203 218 1113 1128 O
for 219 222 1129 1132 O
the 223 226 1133 1136 O
patient 227 234 1137 1144 O
) 234 235 1144 1145 O

tuberculosis 0 12 1146 1158 B-chronic_disease

